{"DataElement":{"publicId":"13722277","version":"1","preferredName":"Filgrastim Or Bioequivalence Agent Dose Reduced Reason","preferredDefinition":"An explanation that describes the reason why the filgrastim or bioequivalence agent dose was reduced.","longName":"13722239v1.00:13722250v1.00","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"13722239","version":"1","preferredName":"Filgrastim Or Bioequivalence Agent Dose Reduced Reason","preferredDefinition":"A recombinant, non-glycosylated cytokine which is chemically identical to or similar to the endogenous cytokine human granulocyte colony-stimulating factor (G-CSF) isoform B, with immunomodulating activity. Filgrastim binds to and activates G-CSF receptors with the same biological activity and stability as the endogenous cytokine, thereby controlling the production, differentiation, and function of neutrophilic granulocyte progenitors._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study. Where there is an intentional difference in rate (e.g., in certain controlled release dosage forms), certain pharmaceutical equivalents or alternatives may be considered bioequivalent if there is no significant difference in the extent to which the active ingredient or moiety from each product becomes available at the site of drug action. This applies only if the difference in the rate at which the active ingredient or moiety becomes available at the site of drug action is intentional and is reflected in the proposed labeling, is not essential to the attainment of effective body drug concentrations on chronic use, and is considered medically insignificant for the drug (21CFR320.1)._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.:An explanation of the cause of some phenomenon or action.","longName":"13722238v1.00:2390595v1.00","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"13722238","version":"1","preferredName":"Filgrastim Or Bioequivalence Agent Dose Reduced","preferredDefinition":"A recombinant, non-glycosylated cytokine which is chemically identical to or similar to the endogenous cytokine human granulocyte colony-stimulating factor (G-CSF) isoform B, with immunomodulating activity. Filgrastim binds to and activates G-CSF receptors with the same biological activity and stability as the endogenous cytokine, thereby controlling the production, differentiation, and function of neutrophilic granulocyte progenitors._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study. Where there is an intentional difference in rate (e.g., in certain controlled release dosage forms), certain pharmaceutical equivalents or alternatives may be considered bioequivalent if there is no significant difference in the extent to which the active ingredient or moiety from each product becomes available at the site of drug action. This applies only if the difference in the rate at which the active ingredient or moiety becomes available at the site of drug action is intentional and is reflected in the proposed labeling, is not essential to the attainment of effective body drug concentrations on chronic use, and is considered medically insignificant for the drug (21CFR320.1)._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","longName":"13722238v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Filgrastim","conceptCode":"C1474","definition":"A recombinant, non-glycosylated cytokine which is chemically identical to or similar to the endogenous cytokine human granulocyte colony-stimulating factor (G-CSF) isoform B, with immunomodulating activity. Filgrastim binds to and activates G-CSF receptors with the same biological activity and stability as the endogenous cytokine, thereby controlling the production, differentiation, and function of neutrophilic granulocyte progenitors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Bioequivalence","conceptCode":"C71763","definition":"The absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study. Where there is an intentional difference in rate (e.g., in certain controlled release dosage forms), certain pharmaceutical equivalents or alternatives may be considered bioequivalent if there is no significant difference in the extent to which the active ingredient or moiety from each product becomes available at the site of drug action. This applies only if the difference in the rate at which the active ingredient or moiety becomes available at the site of drug action is intentional and is reflected in the proposed labeling, is not essential to the attainment of effective body drug concentrations on chronic use, and is considered medically insignificant for the drug (21CFR320.1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose Reduced","conceptCode":"C49505","definition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC9E2F47-E87B-742A-E053-731AD00A6EBF","latestVersionIndicator":"Yes","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2390595","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE52ECB4-C378-617F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC9E2F47-E87C-742A-E053-731AD00A6EBF","latestVersionIndicator":"Yes","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13722250","version":"1","preferredName":"Agent Dose Reduced Reason","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount._An explanation of the cause of some phenomenon or action.","longName":"13722250v1.00","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"120","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Bone pain","valueDescription":null,"ValueMeaning":{"publicId":"2944116","version":"1","preferredName":"Bone Pain","longName":"2944116","preferredDefinition":"Painful sensation in the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Pain","conceptCode":"C38644","definition":"Painful sensation in the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4A92-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E067-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"},{"value":"Donor weight change","valueDescription":null,"ValueMeaning":{"publicId":"13722268","version":"1","preferredName":"Weight Change","longName":"13722268v1.00","preferredDefinition":"An increase or decrease in the weight of an individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight Change","conceptCode":"C9232","definition":"An increase or decrease in the weight of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC9E73F5-E066-0226-E053-731AD00A7F87","latestVersionIndicator":"Yes","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E068-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"},{"value":"Headache","valueDescription":null,"ValueMeaning":{"publicId":"2719266","version":"1","preferredName":"Headache","longName":"2719266","preferredDefinition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Headache","conceptCode":"C34661","definition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4351B20D-E735-1D1B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E069-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"},{"value":"Local (injection site reaction)","valueDescription":null,"ValueMeaning":{"publicId":"2751404","version":"1","preferredName":"Injection Site Reaction","longName":"2751404","preferredDefinition":"An intense reaction (usually immunologic) developing at the site of injection","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injection Site Reaction","conceptCode":"C3508","definition":"An intense reaction (usually immunologic) developing at the site of injection","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0B23-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E06A-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"},{"value":"Low platelet count","valueDescription":null,"ValueMeaning":{"publicId":"12922540","version":"1","preferredName":"Low Platelet Count","longName":"12922540v1.00","preferredDefinition":"A lower than average level of platelets in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Platelet Count","conceptCode":"C162108","definition":"A lower than average level of platelets in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F560907A-5ECA-1670-E053-731AD00AB82C","latestVersionIndicator":"Yes","beginDate":"2023-02-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-23","modifiedBy":"MMADDINENI","dateModified":"2023-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E06B-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"},{"value":"Nausea","valueDescription":null,"ValueMeaning":{"publicId":"5040701","version":"1","preferredName":"Nausea","longName":"5040701","preferredDefinition":"Upper abdominal discomfort associated with an urge to vomit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2354E479-8671-0992-E050-BB89AD433614","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E06C-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"},{"value":"Vomiting","valueDescription":null,"ValueMeaning":{"publicId":"4395791","version":"1","preferredName":"Vomiting","longName":"4395791","preferredDefinition":"Forceful ejection of the contents of the stomach through the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DBF3-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E06D-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"},{"value":"Other reason","valueDescription":null,"ValueMeaning":{"publicId":"7784981","version":"1","preferredName":"Other Reason","longName":"7784981","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An explanation of the cause of some phenomenon or action.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC38E685-3DE7-41A7-E053-4EBD850A0611","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC9E73F5-E06E-0226-E053-731AD00A7F87","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13722249","version":"1","preferredName":"Agent Dose Reduced Reason","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount._An explanation of the cause of some phenomenon or action.","longName":"13722249v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose Reduced","conceptCode":"C49505","definition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC9E47E2-D42E-7A1E-E053-731AD00A936F","latestVersionIndicator":"Yes","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC9E47E2-D42F-7A1E-E053-731AD00A936F","latestVersionIndicator":"Yes","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak2023.5.26 Created per ticket request CADSR0002455. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the reason the filgrastim or bioequivalence agent dose was reduced?","url":null,"context":"NHLBI"},{"name":"NMDP Text 1","type":"Application Standard Question Text","description":"Specify reason(s) for filgrastim or similar dose reduction","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC9E8A82-D6CA-05AC-E053-731AD00A26E3","latestVersionIndicator":"Yes","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"}}